Dawn Christine Maroney Sells 11,152 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 11,152 shares of the firm's stock in a transaction that occurred on Thursday, March 27th. The stock was sold at an average price of $17.89, for a total transaction of $199,509.28. Following the sale, the president now owns 2,362,899 shares of the company's stock, valued at approximately $42,272,263.11. This represents a 0.47 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, March 19th, Dawn Christine Maroney sold 16,535 shares of Alignment Healthcare stock. The stock was sold at an average price of $16.40, for a total value of $271,174.00.
• On Monday, March 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.99, for a total value of $479,700.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total transaction of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.72, for a total transaction of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total value of $408,300.00.

Alignment Healthcare Price Performance

Shares of ALHC stock traded up $0.07 during mid-day trading on Tuesday, reaching $18.69. The company's stock had a trading volume of 1,833,629 shares, compared to its average volume of 1,501,379. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The firm's 50-day moving average is $15.36 and its two-hundred day moving average is $13.06. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $18.92. The company has a market cap of $3.58 billion, a P/E ratio of -24.32 and a beta of 1.49.

Remove Ads

Analysts Set New Price Targets

Several research firms recently weighed in on ALHC. Piper Sandler boosted their target price on Alignment Healthcare from $14.00 to $21.00 and gave the stock an "overweight" rating in a report on Tuesday, March 4th. JPMorgan Chase & Co. upped their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the stock a "neutral" rating in a report on Thursday, March 6th. William Blair reiterated an "outperform" rating on shares of Alignment Healthcare in a report on Friday, February 28th. Bank of America upped their price target on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a "buy" rating in a report on Tuesday, March 4th. Finally, Barclays boosted their price objective on Alignment Healthcare from $8.00 to $9.00 and gave the stock an "underweight" rating in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $14.83.

Institutional Investors Weigh In On Alignment Healthcare

Several large investors have recently modified their holdings of the stock. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Alignment Healthcare in the third quarter valued at $131,000. Intech Investment Management LLC bought a new stake in shares of Alignment Healthcare in the 3rd quarter worth about $315,000. Charles Schwab Investment Management Inc. increased its position in shares of Alignment Healthcare by 1.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 839,695 shares of the company's stock worth $9,925,000 after purchasing an additional 13,865 shares in the last quarter. Algert Global LLC lifted its holdings in Alignment Healthcare by 44.8% during the 3rd quarter. Algert Global LLC now owns 80,903 shares of the company's stock valued at $956,000 after purchasing an additional 25,050 shares during the last quarter. Finally, The Manufacturers Life Insurance Company boosted its position in Alignment Healthcare by 132.2% in the third quarter. The Manufacturers Life Insurance Company now owns 128,933 shares of the company's stock valued at $1,524,000 after buying an additional 73,402 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.